• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

Approval of Multispot HIV-1 / HIV-2 Rapid Test

The Food and Drug Administration (FDA) has approved a marketing application (PMA) for the Multispot HIV-1/HIV-2 Rapid Test. This device is indicated for the detection and differentiation of circulating antibodies associated with HIV-1 and HIV-2 in human plasma and serum, as an aid in the diagnosis of infection with HIV-1 and/or HIV-2.

The test is manufactured by Bio-Rad Laboratories, Redmond, WA.

Additional information about this approval is available on the FDA website:
Letter - (Text)
Summary of Safety and Effectiveness - (PDF)
Label - (PDF)

Richard Klein
HIV/AIDS Program Director
Office of Special Health Issues
Food and Drug Administration